CmaxInsight Market Intelligence: Market Research Reports

... within 1-2 Business Days. CmaxInsight’s, “PDE Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the PDE Inhibitor. Pipeline Covered: This section mentions all the promising therapies ...

... 1-2 Business Days. CmaxInsight’s, “PDE 1 Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ... the client to understand the landscape of the PDE 1 Inhibitor. Pipeline Covered: This section mentions all the promising therapies ...

... 1-2 Business Days. CmaxInsight’s, “PDE 10 inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ... the client to understand the landscape of the PDE 10 inhibitor. Pipeline Covered: This section mentions all the promising therapies ...

... coverage of MoA enables the client to understand the landscape of the Penicillin-Binding Proteins (PBPs) Inhibitor. Pipeline Covered: This section mentions all the promising therapies in different ...

... within 1-2 Business Days. CmaxInsight’s, “Peroxisome Proliferator-Activated Receptor (PPAR) Agonist-Pipeline Intelligence, 2019”, report provides comprehensive ... companies Assess challenges and opportunities that influence Peroxisome Proliferator-Activated Receptor (PPAR) Agonist R&D Please note: Certain sections in ...

... clients within 1-2 Business Days. CmaxInsight’s, “Phosphoinositide 3-Kinase Beta (PI3K Beta) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive ... potential partners with progressing projects for Phosphoinositide 3-Kinase Beta (PI3K Beta) Inhibitor to enhance and expand business ...

... clients within 1-2 Business Days. CmaxInsight’s, “Phosphoinositide 3-Kinase Delta (PI3K Delta) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive ... potential partners with progressing projects for Phosphoinositide 3-Kinase Delta (PI3K Delta) Inhibitor to enhance and expand business ...

... within 1-2 Business Days. CmaxInsight’s, “PI3K Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the PI3K Inhibitor. Pipeline Covered: This section mentions all the promising therapies ...

... 1-2 Business Days. CmaxInsight’s, “PI3K/mTOR Pathway Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the PI3K/mTOR Pathway Inhibitor. Pipeline Covered: This section mentions all the promising ...

... 1-2 Business Days. CmaxInsight’s, “Pim Kinase Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the Pim Kinase Inhibitor. Pipeline Covered: This section mentions all the promising therapies ...

... within 1-2 Business Days. CmaxInsight’s, “Plasmin Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the Plasmin Inhibitor. Pipeline Covered: This section mentions all the promising ...

... Business Days. CmaxInsight’s, “Plasminogen Activator Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... client to understand the landscape of the Plasminogen Activator Inhibitor. Pipeline Covered: This section mentions all the promising ...

... coverage of MoA enables the client to understand the landscape of the Plasminogen Activator Inhibitor-1 (PAI-1). Pipeline Covered: This section mentions all the promising therapies in different ...

... within 1-2 Business Days. CmaxInsight’s, “Plasminogen Activators-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ... client to understand the landscape of the Plasminogen Activators. Pipeline Covered: This section mentions all the promising ...

... clients within 1-2 Business Days. CmaxInsight’s, “Platelet Derived Growth Factor Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights ... leading companies Assess challenges and opportunities that influence Platelet Derived Growth Factor Inhibitor R&D Please note: Certain sections in the ...

... 1-2 Business Days. CmaxInsight’s, “Polo-Like Kinase Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the Polo-Like Kinase Inhibitor. Pipeline Covered: This section mentions all the promising ...

... clients within 1-2 Business Days. CmaxInsight’s, “Polo-Like Kinase 1 (PLK1 )Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights ... leading companies Assess challenges and opportunities that influence Polo-Like Kinase 1 (PLK1 )Inhibitor R&D Please note: Certain sections in the ...

... the clients within 1-2 Business Days. CmaxInsight’s, “Poly (ADP-Ribose) Polymerase 1 (PARP) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights ... identifying potential partners with progressing projects for Poly (ADP-Ribose) Polymerase 1 (PARP) Inhibitor to enhance and expand business ...

... 1-2 Business Days. CmaxInsight’s, “Potassium Channel Openers-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the Potassium Channel Openers. Pipeline Covered: This section mentions all the promising ...

... Business Days. CmaxInsight’s, “PPAR-Beta / Delta Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... the client to understand the landscape of the PPAR-Beta / Delta Agonist. Pipeline Covered: This section mentions all the promising therapies ...

... coverage of MoA enables the client to understand the landscape of the Progesterone Receptor (PR) Antagonist. Pipeline Covered: This section mentions all the promising therapies in different ...

... Business Days. CmaxInsight’s, “Progesterone Receptor Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the Progesterone Receptor Agonist. Pipeline Covered: This section mentions all the promising ...

... Business Days. CmaxInsight’s, “Prolactin Receptor Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the Prolactin Receptor Antagonist. Pipeline Covered: This section mentions all the promising ...

... to the clients within 1-2 Business Days. CmaxInsight’s, “Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor-Pipeline Intelligence, 2019”, report ... identifying potential partners with progressing projects for Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor to enhance and ...

... 1-2 Business Days. CmaxInsight’s, “Prostaglandin Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ... client to understand the landscape of the Prostaglandin Antagonist. Pipeline Covered: This section mentions all the promising ...

... clients within 1-2 Business Days. CmaxInsight’s, “Protein Kinase C (PKC) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights ... leading companies Assess challenges and opportunities that influence Protein Kinase C (PKC) Inhibitor R&D Please note: Certain sections in the report ...

... coverage of MoA enables the client to understand the landscape of the Protein-Tyrosine Phosphatase (PTP) Inhibitor. Pipeline Covered: This section mentions all the promising therapies in different ...

... within 1-2 Business Days. CmaxInsight’s, “Protein-Tyrosine Phosphatase 1B (PTP1B) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive ... companies Assess challenges and opportunities that influence Protein-Tyrosine Phosphatase 1B (PTP1B) Inhibitor R&D Please note: Certain sections in ...

... coverage of MoA enables the client to understand the landscape of the Purinergic Receptor (Purinoceptor) Antagonist. Pipeline Covered: This section mentions all the promising therapies in different ...

... within 1-2 Business Days. CmaxInsight’s, “Renin Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the Renin Inhibitor. Pipeline Covered: This section mentions all the promising ...

... clients within 1-2 Business Days. CmaxInsight’s, “RET (Ret Proto-Oncogene) protein Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights ... companies Assess challenges and opportunities that influence RET (Ret Proto-Oncogene) protein Inhibitor R&D Please note: Certain sections in the ...

... clients within 1-2 Business Days. CmaxInsight’s, “Retinoic Acid Receptors (RARs) Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights ... leading companies Assess challenges and opportunities that influence Retinoic Acid Receptors (RARs) Agonist R&D Please note: Certain sections in the ...

... 1-2 Business Days. CmaxInsight’s, “Reversible Anticholinesterases-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ... client to understand the landscape of the Reversible Anticholinesterases. Pipeline Covered: This section mentions all the ...

... the clients within 1-2 Business Days. CmaxInsight’s, “Rho Kinase (Rho-Associated Coiled-Coil Forming Protein Kinase or ROCK) Inhibitor-Pipeline Intelligence, 2019”, ... potential partners with progressing projects for Rho Kinase (Rho-Associated Coiled-Coil Forming Protein Kinase or ROCK) Inhibitor to enhance and ...

... clients within 1-2 Business Days. CmaxInsight’s, “RNA-Dependent RNA Polymerase (RdRP or RNA Replicase) Inhibitor-Pipeline Intelligence, 2019”, report provides ... potential partners with progressing projects for RNA-Dependent RNA Polymerase (RdRP or RNA Replicase) Inhibitor to enhance and expand ...

... clients within 1-2 Business Days. CmaxInsight’s, “RON (Recepteur d'origine Nantais) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights ... companies Assess challenges and opportunities that influence RON (Recepteur d'origine Nantais) Inhibitor R&D Please note: Certain sections in the ...

... within 1-2 Business Days. CmaxInsight’s, “Sclerostin Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ... the client to understand the landscape of the Sclerostin Inhibitor. Pipeline Covered: This section mentions all the promising ...

... within 1-2 Business Days. CmaxInsight’s, “Secretase Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the Secretase Inhibitor. Pipeline Covered: This section mentions all the promising ...

... within 1-2 Business Days. CmaxInsight’s, “Selectin Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the Selectin Inhibitor. Pipeline Covered: This section mentions all the promising ...

... 1-2 Business Days. CmaxInsight’s, “Selective COX-2 Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the Selective COX-2 Inhibitor. Pipeline Covered: This section mentions all the promising ...

... clients within 1-2 Business Days. CmaxInsight’s, “Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive ... potential partners with progressing projects for Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor to enhance and expand business ...

... Days. CmaxInsight’s, “Serotonin Reuptake Inhibitor (SRI)-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... the client to understand the landscape of the Serotonin Reuptake Inhibitor (SRI). Pipeline Covered: This section mentions all the promising ...

... Business Days. CmaxInsight’s, “Serotonin Transporter Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... client to understand the landscape of the Serotonin Transporter Inhibitor. Pipeline Covered: This section mentions all the promising ...

... 1-2 Business Days. CmaxInsight’s, “Sigma Receptor Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the Sigma Receptor Agonist. Pipeline Covered: This section mentions all the promising therapies ...

... to the clients within 1-2 Business Days. CmaxInsight’s, “Signal Transducer And Activator Of Transcription 3/5 (STAT3/5) Inhibitor-Pipeline Intelligence, 2019”, ... by identifying potential partners with progressing projects for Signal Transducer And Activator Of Transcription 3/5 (STAT3/5) Inhibitor to enhance ...

... to the clients within 1-2 Business Days. CmaxInsight’s, “Sodium Dependent Glucose Transporter 1 (SGLT1) Inhibitor-Pipeline Intelligence, 2019”, report provides ... by identifying potential partners with progressing projects for Sodium Dependent Glucose Transporter 1 (SGLT1) Inhibitor to enhance and expand ...

... Business Days. CmaxInsight’s, “Somatostatin Receptor Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the Somatostatin Receptor Agonist. Pipeline Covered: This section mentions all the promising ...

... coverage of MoA enables the client to understand the landscape of the Sphingosine 1-Phosphate (S1P) Inhibitor. Pipeline Covered: This section mentions all the promising therapies in different ...

... within 1-2 Business Days. CmaxInsight’s, “Sphingosine 1-Phosphate (S1P) Receptor Agonist-Pipeline Intelligence, 2019”, report provides comprehensive ... companies Assess challenges and opportunities that influence Sphingosine 1-Phosphate (S1P) Receptor Agonist R&D Please note: Certain sections in the ...

... Business Days. CmaxInsight’s, “Squalene Epoxidase Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the Squalene Epoxidase Inhibitor. Pipeline Covered: This section mentions all the promising ...